85.43
0.60%
0.51
Vorhandelsmarkt:
84.73
-0.70
-0.82%
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-30 | 2023-12-30 | 2023-09-30 | 2023-07-01 | 2023-04-01 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
2.09%
343.29
|
336.25 | 318.18 | 311.33 | 304.42 |
Cost Of Revenue |
5.68%
167.38
|
158.38 | 147.67 | 144.07 | 148.17 |
Gross Profit |
1.10%
175.91
|
177.87 | 170.51 | 167.26 | 156.25 |
Operating Expenses
|
10.67%
145.96
|
131.89 | 135.21 | 113.61 | 120.99 |
Benefits Costs and Expenses |
9.46%
319.88
|
292.22 | 285.35 | 259.74 | 271.79 |
Costs And Expenses |
9.46%
319.88
|
292.22 | 285.35 | 259.74 | 271.79 |
Depreciation and Amortization |
17.46%
27.64
|
23.53 | 23.01 | 23.03 | 23.85 |
Operating Income/Loss |
34.88%
29.94
|
45.98 | 35.30 | 53.66 | 35.26 |
Income/Loss From Continuing Operations Before Tax |
46.82%
23.41
|
44.03 | 32.83 | 51.59 | 32.63 |
Income Tax Expense/Benefit |
76.17%
3.047
|
12.79 | 7.924 | 10.55 | 3.243 |
Income/Loss From Continuing Operations After Tax |
34.81%
20.37
|
31.24 | 24.91 | 41.04 | 29.38 |
Net Income/Loss
|
34.81%
20.37
|
31.24 | 24.91 | 41.04 | 29.38 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.95%
0.027
|
50.77 | 50.73 | 50.54 | -0.113 |
Diluted Average Shares |
99.99%
0.003
|
51.45 | 51.40 | 51.34 | -0.067 |
Basic Earnings Per Share |
35.48%
0.40
|
0.62 | 0.49 | 0.81 | 0.58 |
Diluted Earnings Per Share |
34.43%
0.40
|
0.61 | 0.48 | 0.80 | 0.57 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):